Insider Buying: DelMar Pharmaceuticals CEO Purchases 5,000 Shares of Stock (DMPI)
DelMar Pharmaceuticals (NASDAQ:DMPI) CEO Jeffrey Bacha acquired 5,000 shares of the stock in a transaction dated Friday, February 21st. The shares were purchased at an average price of $1.00 per share, for a total transaction of $5,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 32,000 shares in the company, valued at approximately $32,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
DelMar Pharmaceuticals (NASDAQ:DMPI) opened at 1.00 on Monday. DelMar Pharmaceuticals has a 52 week low of $0.751 and a 52 week high of $2.50. The stock has a 50-day moving average of $0.91 and a 200-day moving average of $1.0. The company’s market cap is $24.0 million.
DelMar Pharmaceuticals, Inc formerly Berry Only Inc, is developing new drug candidates targeting orphan cancer indications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.